Last reviewed · How we verify
NCT04859062
Lidocaine Gel 2% and Muscle Traction Pain During Squint Surgery in Pediatrics
NA trial testing lidocaine gel 2% in Squint in 40 participants. Completed in 1 April 2022.
1 April 2022
Quick facts
| Lead sponsor | Research Institute of Ophthalmology, Egypt |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 1 August 2021 |
| Primary completion | 1 April 2022 |
| Estimated completion | 1 April 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- lidocaine gel 2% — full drug profile →
- control group — full drug profile →
Conditions studied
- Squint — all drugs for Squint →
Sponsor
Research Institute of Ophthalmology, Egypt
Who can join
Adults 2 to 13, any sex, with Squint. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assessing the efficacy of lidocaine gel 2% application 10 minutes before surgery on post operative pain and the use of analgesics postoperatively
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04859062
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of lidocaine gel 2%
Trials testing the same drug.
- NCT03847922 — Nitrous Oxide for Analgesia During Office Urethral Bulking · Phase 4 · terminated
Other Research Institute of Ophthalmology, Egypt trials
Trials by the same sponsor.
- NCT05539924 — Pregabalin Versus Gabapentin Opioid Sparing Effect in Discectomy · Phase 3 · unknown
- NCT05728151 — Comparing General Anesthesia With Single Injection Peribulbar Block With 3 Different Drugs · NA · completed
- NCT04859049 — Single Injection Infromedial Peribulbar Injection in Lacrimal Duct · NA · unknown
- NCT05069350 — Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI · EARLY_PHASE1 · completed
- NCT05031312 — Inferior Oblique Myectomy Versus Anterior and Nasal Transposition of Its Tendon for Treatment of Superior Oblique Muscle · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04859062 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Research Institute of Ophthalmology, Egypt
- Last refreshed: 19 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04859062.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing